Bryan Rynearson, MD
Orthopaedic Surgery of the Spine · Saint Louis, MONPI 1851772586
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $12,230 of the $16,770 with a category attached, or 72.9%. 16 manufacturers reported payments, led by Abbott at 44.8% of the total.
Across 211 payments — averaging $79.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$8K
- Medtronic$2K
- Si-bone, Inc.$2K
- Globus Medical$2K
- Stryker$791
- Synthes GmbH$541
- plus $2K from 10 others
What the payments were for
- Consulting fees$2251%
- Travel & lodging$3,83923%
- Food & beverage$12,23073%
- Education$4763%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 100 | $7,513 |
| Medtronic | 39 | $2,197 |
| Si-bone, Inc. | 21 | $1,823 |
| Globus Medical(2 entities) | 18 | $1,766 |
| Stryker | 7 | $791 |
| Synthes GmbH | 1 | $541 |
| Johnson & Johnson(2 entities) | 6 | $533 |
| Cerapedics Inc. | 7 | $358 |
| Baxter Healthcare | 3 | $265 |
| Boston Scientific | 3 | $245 |
| The Institute Of Musculoskeletal Science And Education | 1 | $225 |
| Biocomposites Inc | 1 | $182 |
| Innovation Technologies Inc | 1 | $166 |
| Electronic Waveform Lab, Inc. | 1 | $70 |
| Alphatec Spine, Inc | 1 | $59 |
| Bioventus LLC | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$4,101
- ETERNA$862
- XLIF$752
- IFUSE IMPLANT SYSTEM$708
- NONE$415
- INCEPTIV$409
- Excelsius - GPS$372
- PENTA$340
- ALIF$329
- SYMPHONY$263
- Excelsius Spine 1.1$229
- I-FACTOR PEPTIDE ENHANCED BONE GRAFT$196
- Stimulan$182
- ANTERALIGN SPINAL SYSTEM WITH TITAN NANOLOCK SURFACE TECHNOLOGY$170
- Irrisept$166
- UNID_PASS$165
- ACP$164
- INTELLIS ADAPTIVESTIM$155
- Intracept$154
- EXPEDIUM$153
How this compares
$16,770 in reported general payments places this provider in the 55th percentile of 53 orthopaedic surgery of the spine providers in Missouri.
See all orthopaedic surgery of the spine providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methocarbamol | 113 | $872 |
| Gabapentin | 75 | $727 |
| Cyclobenzaprine Hcl | 19 | $282 |
| Methylprednisolone | 22 | $152 |
| Meloxicam | 56 | $134 |
| Mupirocin | 16 | $91 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery of the spine in Saint Louis
- Munish GuptaSaint Louis$1M
- Jacob BuchowskiSaint Louis$658K
- Brian NeumanSaint Louis$106K
- R Adams CowleySaint Louis$53K
- Michael ReiterSaint Louis$37K
- Mark LambrechtsSaint Louis$37K
- Nicholas PallottaSaint Louis$21K
- Matthew GoodwinSaint Louis$20K
- John ClohisySaint Louis$19K
- Diana DoulehSaint Louis$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.